PMS-EVEROLIMUS

Identification of Pms-Everolimus

No description

Google image searchProduct monograph

Active ingredient

everolimus, 2.5 MG

DIN: 02504677

Dosage form(s): TABLET

Route(s) of administration: ORAL

Schedule: Prescription

Company: PHARMASCIENCE INC

Date: 08-SEP-2021

ATC:

• L04 — IMMUNOSUPPRESSANTS (ATC, ATC/DDD, )
• L04A — IMMUNOSUPPRESSANTS (ATC, ATC/DDD)
• L04AH — Mammalian target of rapamycin (mTOR) kinase inhibitors (ATC, ATC/DDD)
• L04AH02 — EVEROLIMUS (ATC/DDD)

Reference brand drug: Afinitor

Pharmaceutical standard: MFR

External Links for Pms-Everolimus

Search on Google

• Pms-Everolimus side effects
• Pms-Everolimus dosage
• everolimus side effects
• everolimus dosage

Pharmascience Inc

Go to Pharmascience website to see drug product details. Sometimes you can find pms-everolimus photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.